Drug class
Trivalent organoarsenical antiprotozoal; antitrypanosomal agent
Mechanism of action
An arsenical compound that reacts with parasite thiol-containing molecules, particularly trypanothione, disrupting redox homeostasis and essential metabolic enzyme activity in Trypanosoma brucei.
General use cases
- Treatment of second-stage (meningoencephalitic) human African trypanosomiasis caused by Trypanosoma brucei rhodesiense, when central nervous system involvement is present and according to WHO/national treatment guidance.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
